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VENLAFAXINE -INDUCED ORTHOSTATIC HYPOTENSION
Sir,
Venlafaxine is a selective serotoninnoradernaline reuptake inhibitor available in the Indian market in immediate and extended release (XR) preparations. Although dose-related hypertension is the commonly reported adverse effect of this drug with an incidence ranging form 3 to 13 % depending on the dose (Beauclair et al., 2000) , we describe a patient who developed unexpected orthostatic hypotension and had no underlying cardiac compromise P.T., a 46-year-old male diagnosed with treatment-resistant bipolar depression was started on venlafaxine-XR at a dose of 37.5 mg/day Then next dose hike was by 37.5 mg/day after four days with subsequent increase by 75 mg/day after a week's interval till a dose of 225 mg/day. His base line blood pressure before commencing venlafaxine was 110/70 mmHg. At a dose of 225 mg/day, the patient started experiencing episodes of severe dizziness on getting up and even had a fall on two occasions. Blood pressure record showed a significant postural drop from 100/70 mmHg in the supine position to 50 mmHg systolic blood pressure with the diastolic component not recordable in the standing position. On reducing the dose of venalfaxine to 150 mg/day, there was a significant improvement in both the postural drop and the patient's subjective condition with the former remitting completely after a week of reducing venlafaxine. There was no dysfunction of other autonomic functions or cardiac abnormality or any other evidence to suggest any central nervous system pathology. A previous cranial CT scan showed mild cerebral atrophy but revealed no discernible cause for this postural drop. As he was on two drugs, venlafaxine-XR (225 mg/day) and valproate (600 mg/day) we speculated that either of these two or an interaction between these might have lead to the orthostatic hypotension. However, there was no evidence in literature to implicate valproate alone or in combination with venlafaxine for this presentation. As reduction in the dose of venlafaxine paralleled the improvement in orthostatic hypotension, it was tempting to speculate that venlafaxine may have caused this picture. Indeed, some evidence did emanate to support this contention.
An EMBASE Psychiatry CD-ROM search using the key words 'orthostatic hypotension' and 'venlafaxine' along with a manual search yielded few reports citing the existence of this adverse effect with venlafaxine. According to one source book on drugs, postural hypotension occurred in 1 % out of 1033 subjects on venlafaxine as compared to nil out of 609 subjects on placebo (Facts and Comparison, 1998) . Another study demonstrated unexpected orthostatic hypotension in 13 out of 18 patients who incidentally had some cardiac decompensation as well (Wiese & Alderman, 1999) . In the same study, the orthostatic hypotension was more severe at the initiation of treatment and when the dose was increased, a finding concurring with ours in this patient. The rate of orthostatic hypotension with venlafaxine is comparable with rates seen with selective serotonin reuptake inhibitors (Feighner etal., 1994) . The underlying mechanism for this adverse reaction of venlafaxine is speculative. Blocking of post-synaptic a 1 -adrenergic receptors, which is responsible for orthostatic hypotension, is minimal for venlafaxine in view of its considerably lower affinity than tricyclic antidepressants for binding with this receptor site (Holliday & Benfield, 1995) . However, some binding with these receptors still occurs which may be idiosyncratically high in some patients resulting in a postural drop.
Thus to conclude a clinician needs to bear in mind that venalfaxine, besides causing the usually known adverse effect of hypertension, can also lead to a significant orthostatic hypotension especially at higher doses. Whether this adverse affect is related to an underlying cardiac compromise or occurs idiosyncratically or is a harbinger of incipient dysautonomia needs to be addressed. 
COMPULSIVE JOKING
Sir,
Compulsive rituals or acts are stereotyped behaviors that are neither enjoyable nor do they result in the completion of inherently useful tasks (World Health Organization, 1992) . Herein we report a patient who presented to us with a rare compulsion of cutting jokes, a phenomenon which is unknown in the literature.
A 32 year old male, well adjusted premorbidly, having no contributing past and family history, presented with a continuous illness of two years duration. To begin with, he started stealing things without reasons. When his father scolded, he told him that he had done it "just like that". Simulaneously, he also began spending more time in bathing as well as in religious rituals and started cutting jokes repeatedly. Every time he would tell the same set of 8-10 jokes at one go in a particular order. He would narrate the jokes in a • flat, monotonous voice as if it was a tidious, joyless chore. The jokes were inane and rather mirthless. He never seemed to draw pleasure or joy from telling the jokes. His face would appear tense and he seemed under a compulsion to finish an unpleasant task. Once initiated, he had to complete the entire set of jokes and felt very uneasy if the listener tried to escape. Rather, he would not allow the listeners to move until he had finished his stock of 8-10 jokes. He was hopeless, had no control of his behavior and was often ridiculed for it. Whenever he was asked the reason for cutting such flat jokes, the only answer used to be "just like that".
Gradually within a year.all his unsuual behaviors except cutting jokes disappeared though he additionally developed overconcern about killing small insects and ants while walking and counting his steps while climbing and walking. Along wih this, he also became aloof and socially withdrawn. He had no depressive cognition or features suggestive of another psychiatric illness. On admission, because of his uncooperativeness, except stereotyped reeling out of jokes, no other psychopathology could be elicited. With the diagnosis of mania, treatment was initiated with trifluperazine 15 mg/day; however, he had no improvement with four weeks trial of trifluperazine. During subsequent examinations, he was found to have poor socialization, anxious affect, compulsion of cutting jokes with lack of control over the act and mounting inner tension when the act was prevented and intermittent third person auditory hallucinations. Following this, his diagnosis was changed to obsessive-compulsive disorder (OCD), with predominantly compulsions and paranoid schizophrenia (World Health Organisation, 1992) . He did not improve with initial trials of fluoxetine 20-60 mg/day with haloperidol 5 mg/day(three weeks) and ECT (six) with fluphenthixol 3-6 mg/day (two weeks). However, later on, after a month of combination therapy including clomipramine 75-150 mg/day, carbamazepine 600 mg/day and buspirone 1 mg/ day (augmentation) and olanzapine 10 mg/day, all his psychopathology but auditory hallucinations and withdrawn behaviour disappeared. At that time, he was discharged from the hospital and subsequently he was lost to follow-up.
Although there are no previous reports and no obsession could be elicited, we considered cutting jokes as a compulsive phenomenon because the act of cutting jokes was repetitive, non-pleasurable, and uncontrollable and the subject felt mounting inner tension when he could
